IL239623A0 - שיטות ותכשירים למתן אוקסיבוטינין - Google Patents

שיטות ותכשירים למתן אוקסיבוטינין

Info

Publication number
IL239623A0
IL239623A0 IL239623A IL23962315A IL239623A0 IL 239623 A0 IL239623 A0 IL 239623A0 IL 239623 A IL239623 A IL 239623A IL 23962315 A IL23962315 A IL 23962315A IL 239623 A0 IL239623 A0 IL 239623A0
Authority
IL
Israel
Prior art keywords
admisitration
oxybutynin
compositions
methods
Prior art date
Application number
IL239623A
Other languages
English (en)
Original Assignee
Microdose Therapeutx Inc
Cook Robert
Byron David A
Fleming Scott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/728,706 external-priority patent/US9119777B2/en
Application filed by Microdose Therapeutx Inc, Cook Robert, Byron David A, Fleming Scott filed Critical Microdose Therapeutx Inc
Publication of IL239623A0 publication Critical patent/IL239623A0/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL239623A 2012-12-27 2015-06-24 שיטות ותכשירים למתן אוקסיבוטינין IL239623A0 (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/728,706 US9119777B2 (en) 2008-05-30 2012-12-27 Methods and compositions for administration of oxybutynin
PCT/US2013/074759 WO2014105446A1 (en) 2012-12-27 2013-12-12 Methods and compositions for administration of oxybutynin

Publications (1)

Publication Number Publication Date
IL239623A0 true IL239623A0 (he) 2015-08-31

Family

ID=51021931

Family Applications (1)

Application Number Title Priority Date Filing Date
IL239623A IL239623A0 (he) 2012-12-27 2015-06-24 שיטות ותכשירים למתן אוקסיבוטינין

Country Status (15)

Country Link
EP (1) EP2938329A4 (he)
JP (1) JP2016504358A (he)
KR (1) KR20150100902A (he)
CN (1) CN104955444A (he)
AR (1) AR094287A1 (he)
AU (1) AU2013368298B2 (he)
BR (1) BR112015015421A2 (he)
CA (1) CA2895955A1 (he)
EA (1) EA201591218A1 (he)
HK (2) HK1215396A1 (he)
IL (1) IL239623A0 (he)
MX (1) MX2015008333A (he)
NZ (1) NZ628479A (he)
UY (1) UY35230A (he)
WO (1) WO2014105446A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3421049B1 (en) * 2016-02-25 2020-07-29 Hisamitsu Pharmaceutical Co., Inc. Liquid external preparation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003500354A (ja) * 1999-05-20 2003-01-07 セプラコール, インク. S−オキシブチニンを用いる喘息の治療方法
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
CA2498189A1 (en) * 2002-10-29 2004-05-13 Pharmacia & Upjohn Company Llc Quaternary ammonium compounds
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
CA2585122A1 (en) * 2004-10-25 2006-05-04 Schering Corporation M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
CA2716936C (en) * 2008-02-26 2018-06-05 Elevation Pharmaceuticals, Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
AU2010260513A1 (en) * 2009-06-16 2012-02-02 Wen Tan Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
WO2011120779A1 (en) * 2010-04-01 2011-10-06 Chiesi Farmaceutici S.P.A. Process for preparing carrier particles for dry powders for inhalation
CA2812952A1 (en) * 2010-09-27 2012-04-12 Microdose Therapeutx, Inc. Methods and compositions for disease treatment using inhalation

Also Published As

Publication number Publication date
KR20150100902A (ko) 2015-09-02
WO2014105446A1 (en) 2014-07-03
BR112015015421A2 (pt) 2017-07-11
JP2016504358A (ja) 2016-02-12
AR094287A1 (es) 2015-07-22
CN104955444A (zh) 2015-09-30
AU2013368298A1 (en) 2015-07-02
EA201591218A1 (ru) 2015-11-30
EP2938329A1 (en) 2015-11-04
HK1216843A1 (zh) 2016-12-09
NZ628479A (en) 2016-06-24
EP2938329A4 (en) 2016-08-10
CA2895955A1 (en) 2014-07-03
MX2015008333A (es) 2015-11-09
HK1215396A1 (zh) 2016-08-26
UY35230A (es) 2015-01-30
AU2013368298B2 (en) 2016-08-11

Similar Documents

Publication Publication Date Title
HK1251246A1 (zh) 用於使組合物脫硫的方法和組合物
IL272539B (he) תכשירים ושיטות לאימונותרפיה
AP3965A (en) Anthelminitic compounds and compositions and method of using thereof
HK1204330A1 (en) Factor viii compositions and methods of making and using same viii
ZA201508059B (en) Compositions and methods of use of phorbol esters
EP2836224A4 (en) COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
EP2834322A4 (en) BIOCHARBON COMPOSITIONS AND METHODS OF USE
EP2675471A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
EP2836212A4 (en) NOVEL COMPOSITIONS AND METHOD
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
EP2917314A4 (en) OLIGOMERATZUSAMMENSETZUNG
EP2672822A4 (en) METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS
IL227924B (he) תכשירים ושיטות שימוש לקביעת a4he
EP2906041A4 (en) COMPOSITIONS AND METHODS OF USING INAPPETENCE COMPOUND
EP2931280A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING CNKSR1
EP2867199A4 (en) STABLE COMPOSITIONS OF ESOTRERODINE
EP2852662A4 (en) HERPESVIRUS COMPOSITIONS AND RELATED METHODS
IL239623A0 (he) שיטות ותכשירים למתן אוקסיבוטינין
HK1212998A1 (zh) 組合物及其使用方法
EP2841164A4 (en) COMPOSITIONS AND USE PROCEDURES FOR THE SKIN